Chx Technologieschxis A Specialty Pharmaceutical Company Introducing A Newhigh Strengthsustained Release Antiseptic Tooth Coating Which Manages The Cause Of Poor Oral Healthan Imbalance Of Bacteria In The Dental Plaque Called Oral Dysbiosisthis Coating Has First In Class Approvals In Canada And The Eu For Preventing Dental Decay In High Risk Adultschx Is Working On Expanding This Indication To Include Periodontal Disease And Prevora S Use In The Management Of Type 2 Diabetessystemic Inflammation And Cognitive Declineprevora Is Used By Hygienists Where High Risk Adults Are Foundthe Physician S Officethe Hospital Serving Special Needs And Complex Needs Patientsand In Geriatric Carethese Venues Seek To Improve Oral Health Cost Effectively As Part Of Integrated Care And Chronic Disease Management There Are Some 125 Million Adults With Poor Oral Health In North America And Western Europemaking It The Largest Unmet Need In Pharmaceuticals
